Cellics Therapeutics is a preclinical stage company, developing therapies for various diseases using cell membrane coating technology. The company's proprietary Nanosponge Technology is based on coating nanoparticles and nanomaterials with cellular membranes taken directly from cells. The company focuses on the development of red blood cell membrane (RBC) coated Nanosponges to develop therapies for infectious diseases, autoimmune disorders, anti-venom, and vaccines. The company claims that the n Founded in 2014, headquartered in San Diego, United States. The company has raised $26M at the Series B stage backed by investors including CARB-X, Cash Capital. Operating in Life Sciences > Drug Delivery, High Tech > Nanotechnology.
← All startups
Cellics
Series BCellics Therapeutics is a preclinical stage company, developing therapies for various diseases using cell membrane coating technology. The company's proprietary Nanosponge Technology is based on coating nanoparticles and nanomaterials with cellular membranes taken directly from cells. The company focuses on the development of red blood cell membrane (RBC) coated Nanosponges to develop therapies for infectious…
About
Business model
Nanotechnology > Nanoenabled Products > Life Science > Drugs,
Drug Delivery > Diversified
Institutional investors
CARB-XCash Capital
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Investor directory
🗂️ Explore Life Sciences investors — funds that write checks in this sector.